肝门部胆管癌外科治疗及临床疗效分析41例  

Curative effect of surgical treatment of hilar cholangiocarcinoma: Analysis of 41 cases

作　　者：闫鹏展[1] 赵礼金[1] 涂奎[1] 王芳[1] 

机构地区：[1]遵义医学院附属医院肝胆胰外科,贵州省遵义市563000

出　　处：《世界华人消化杂志》2015年第16期2614-2618,共5页World Chinese Journal of Digestology

基　　金：国家自然科学基金资助项目;No.81260085~~

摘　　要：目的:探讨外科手术在肝门部胆管癌(hilar cholangiocarcinoma,HC)治疗中的疗效.方法:回顾性分析2007-10/2010-03遵义医学院附属医院肝胆胰外科收治的41例肝门部胆管癌患者的临床资料.结果:41例患者术后并发症发生率为36.59%(15/41).包括术后切口感染2例,肺部感染3例,胆漏3例,并发胸腹水7例.根治性切除组术后1、3、5年生存率分别为:78.6%、42.9%、21.4%,姑息性手术切除组术后仅为41.7%、16.7%和0.0%,减黄治疗组术后生存率分别为:25.0%、8.3%、0.0%.结论:根治性手术切除可明显提高肝门部胆管癌患者生存率.AIM：To explore the curative effect of surgery in the treatment of hilar cholangiocarcinoma（HC）.METHODS：A retrospective analysis was performed of the clinical data for 41 HC patients treated from October 2007 to March2010 in Affiliated Hospital of Zunyi Medical College.RESULTS：In the 41 patients,the incidence of postoperative complications was 36.59%,including incision infection in 2 cases,pulmonary infection in 3 cases,bile leakage in 3 cases,and pleural effusion in 7 cases.After radical resection,the 1-,3-,and 5-year survival rates were 78.6%,42.9%and 21.4%,respectively.After palliative resection,the 1-,3-,and 5-year survival rates were 41.7%,16.7%and 0.0%,respectively.In the conservative treatment（jaundice control） group,the 1-,3-,and 5-year survival rates were 25.0%,8.3%and0.0%,respectively.

关 键 词：肝门部胆管癌 根治性切除 生存率 

分 类 号：R735.8[医药卫生—肿瘤]